In Other News

• Thermo Fisher Scientific to Sell Microbiology Business to Astorg

• Proteomic Risk Score Predicts Kidney Disease Progression in High-Risk Patients

• Blood Test Enables Early Detection of Multiple Myeloma Relapse

• Study Highlights Low Sensitivity of Current Lyme Tests in Early Infection

• New Molecular Insights Support Diagnosis of Hodgkin Lymphoma

• Routine Blood Tests Identify Biomarkers Linked to PTSD

• Risk Prediction Tool Enhances Genetic Testing for Li-Fraumeni Syndrome

• Microfluidic Single-Cell Assay Predicts Breast Cancer Risk

• Genetic Signature Predicts Myeloid Leukemia Risk in Down Syndrome

• Epigenetic Signals and Blood Markers Aid Chronic Fatigue Syndrome Diagnosis

• New Molecular Insights Support Diagnosis of Hodgkin Lymphoma

• Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour

• Gene Expression Model Guides Neoadjuvant Therapy Selection in Breast Cancer

• Collaboration Expands Access to Rapid Metagenomic Diagnostics for Complex Infections

• Collaboration Expands Access to Rapid Metagenomic Diagnostics for Complex Infections

• Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

• Microenvironment Biomarkers Could Enable Early Lung Cancer Detection

• Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

• Interpretable AI Reveals Hidden Cellular Features from Microscopy Images

• AI Blood Test Enhances Monitoring of Liver Cirrhosis Progression

• Routine Blood Count Ratio Linked to Future Alzheimer’s and Dementia Risk

• Label-Free Microfluidic Device Enriches Tumor Cells and Clusters from Pleural Effusions

• Tumor Immune Structure Predicts Response to Immunotherapy in Melanoma